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Abstract Erythrocytes can reduce extracellular ascorbate free
radicals by a plasma membrane redox system using intracellular
ascorbate as an electron donor. In order to test whether the redox
system has electrogenic properties, we studied the effect of
ascorbate free radical reduction on the membrane potential of the
cells using the fluorescent dye 3,3P-dipropylthiadicarbocyanine
iodide. It was found that the erythrocyte membrane depolarized
when ascorbate free radicals were reduced. Also, the activity of
the redox system proved to be susceptible to changes in the
membrane potential. Hyperpolarized cells could reduce ascorbate
free radical at a higher rate than depolarized cells. These results
show that the ascorbate-driven reduction of extracellular
ascorbate free radicals is an electrogenic process, indicating that
vectorial electron transport is involved in the reduction of
extracellular ascorbate free radical. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Ascorbate, or vitamin C, is involved in the protection of an
organism against a variety of oxidative agents [1,2]. However,
the reaction with an oxidant consumes ascorbate, thus leading
to loss of the vitamin. Oxidation of ascorbate usually takes
place in two one-electron steps, the ¢rst of which results in the
ascorbate free radical (AFR) [3]. AFR can be oxidized fur-
ther, producing dehydroascorbic acid (DHA). Also, two mol-
ecules of AFR can disproportionate, forming one DHA and
one ascorbate molecule. The ring structure of DHA is easily
opened by an irreversible hydrolysis reaction [4]. Hence, fail-
ure to quickly reduce oxidation products of ascorbate will
lead to loss of the vitamin. To prevent ascorbate depletion,
DHA and AFR can be reduced by a number of systems, most
of which are located in the cytoplasm of the cell. The con-
versions are mainly enzymatic, by e.g. glutaredoxin, thio-
redoxin reductase, or AFR reductases, but a chemical reduc-
tion by glutathione alone has also been described [5^9]. When
an oxidation occurs extracellularly, the product DHA can be
transported into the cell for reduction. For erythrocytes, it has
also been described that AFR and DHA can be reduced ex-
tracellularly by redox enzymes in the plasma membrane,
which are thought to use intracellular NADH as a source of
reducing equivalents [10,11]. Recently, we found evidence for
an alternative pathway for the reduction of extracellular AFR
in the erythrocyte (Fig. 1) [12]. Not NADH, but intracellular
ascorbate provided the reducing equivalents for this reaction,
which may involve a transmembrane redox enzyme. The re-
action has high similarity to a redox process in the adrenal
chroma⁄n granules. In these granules, a cytochrome b561 is
involved in the transmembrane reduction of AFR by ascor-
bate [13^15]. Earlier, we investigated whether this cytochrome
was also expressed in the erythrocyte, but it was found that
this was not the case [16]. It is possible that another, similar,
erythrocyte redox system is responsible for the reduction of
AFR. On the other hand, it has also been suggested that
electrons can be transported over the membrane by small lipid
soluble molecules like K-tocopherol and coenzyme Q [17^19].
Thus, the mechanism of the redox system remains unresolved.
This paper further investigates the mechanism of the reduc-
tion of extracellular AFR by intracellular ascorbate. Previous
data indicated that an electron is abstracted from intracellular
ascorbate, and transported over the membrane. In principle,
such a movement of charge is electrogenic, and could change
the potential of the plasma membrane. Other transmembrane
redox processes were indeed shown to be electrogenic. In cells
and vesicles from di¡erent cell types and species, the reduction
of extracellular substrates like ferricyanide was found to a¡ect
the membrane potential, resulting in depolarization [20^24].
To test whether the reduction of AFR by the plasma mem-
brane redox system of erythrocytes has electrogenic proper-
ties, changes in the membrane potential were studied using a
potential sensitive £uorescent carbocyanine probe. Moreover,
the e¡ect of di¡erent membrane potentials on the reductase
activity was determined. It is concluded that the ascorbate-
driven plasma membrane redox system indeed catalyzes elec-
trogenic AFR reduction, and that it is not likely that small
electron carriers are involved in the transfer of electrons over
the plasma membrane.
2. Materials and methods
Chemicals were from Sigma (Zwijndrecht, The Netherlands) unless
speci¢ed otherwise. Ascorbate oxidase (EC 1.10.3.3) was purchased as
sticks containing 17 U of enzyme (Roche Diagnostics, Almere, The
Netherlands), and was freshly dissolved before use by gentle mixing
for 30 min. Erythrocytes were obtained from 1-day old citrate-anti-
coagulated blood, collected from healthy human volunteers by the
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Bloodbank Leiden/Haaglanden (Leiden, The Netherlands). The cells
were washed three times in 20 mM Tris, 150 mM NaCl pH 7.4 (Tris/
NaCl). The bu¡y coat of white cells was removed carefully with each
wash.
Erythrocytes were loaded with ascorbate by resuspending cells to a
hematocrit of 20% in Tris/NaCl with 500 WM DHA, and 2.5 mM
adenosine as an energy-source [25]. Control erythrocytes were treated
similarly, but without DHA. After 30 min of incubation at room
temperature, the erythrocytes were washed three times with Tris/
NaCl, and used within 1 h for subsequent experiments. As described
before, ascorbate-loaded erythrocytes contained 1 mM ascorbate,
while control erythrocytes contained up to 50 WM endogenous ascor-
bate [12]. All experiments were performed in Tris/NaCl, or, where
indicated, in a similar bu¡er where a part of the NaCl was replaced
by KCl.
Membrane potentials were determined using the potential sensitive
dye 3,3P-dipropylthiadicarbocyanine iodide (DiSC3(5), Molecular
Probes, Leiden, The Netherlands) [26]. 1 WM of dye was added to a
1% suspension of erythrocytes in a stirred plastic cuvette, and £uo-
rescence was monitored using a Perkin-Elmer LS-50B £uorimeter and
FL Winlab 3.0 software (Perkin-Elmer Benelux, Oosterhout, The
Netherlands). The excitation wavelength was set at 640 nm, and emis-
sion at 670 nm, both using a 10-nm slit.
The concentration of AFR was determined using electron spin res-
onance (ESR) spectroscopy. Spectra were obtained using a JEOL-
RE2X spectrometer operating at 9.36 GHz with a 100-kHz modula-
tion frequency, equipped with a TM110 cavity. Immediately after mix-
ing, the samples were transferred to the quartz £at cell by means of a
rapid sampling device, and a spectrum was recorded using a 2-min
scan time. The area under the ESR absorption curve, as determined
by double integration, is proportional to the amount of paramagnetic
species in the sample, and this can be used as a quantitative assay.
The concentration of AFR was determined by double integration of
the ESR spectra, using 2,2,6,6-tetramethylpiperidine-N-oxyl (TEM-
PO) as a standard. The spectra were obtained with the same instru-
ment settings as used for collecting the experimental spectra, except
for receiver gain. ESR spectrometer setting were as follows: micro-
wave power, 40 mW; modulation amplitude, 0.63 G; time constant,
0.03 s; scan time, 2 min; scan width, 25 G.
The reduction of AFR was measured indirectly by monitoring the
oxidation of 100 WM ascorbate (Aldrich, Zwijndrecht, The Nether-
lands) in a 10% suspension of erythrocytes [12]. AFR was generated
by oxidizing 100 WM ascorbate with 10 mU/ml of ascorbate oxidase.
At 0 and 15 min, a sample of the suspension was centrifuged, and the
amount of ascorbate remaining in the supernatant was measured im-
mediately. The rate of ascorbate oxidation in the sample is determined
from the di¡erence in concentration between 0 and 15 min. Ascorbate
concentrations were determined by measuring the absorption at 265
nm in a Beckman DU-65 spectrophotometer (extinction coe⁄-
cient = 14 500 M31 cm31).
All experiments were performed at least three times, and error bars
represent the standard deviation where applicable.
3. Results and discussion
3.1. The e¡ect of AFR on the membrane potential
Addition of 1 WM DiSC3(5) to ascorbate-loaded or control
erythrocytes induced a sharp increase in £uorescence, fol-
lowed by equilibration at a lower level after the dye parti-
tioned between the medium and the cells (Fig. 2). Subse-
quently, 100 WM ascorbate and 42.5 mU/ml ascorbate
oxidase were added in order to generate ascorbate radicals
in the suspension. As shown in Fig. 2, AFR had no measur-
able e¡ect on the £uorescence in the presence of control
erythrocytes. However, in the presence of ascorbate-loaded
erythrocytes the £uorescence increased, indicating a depolari-
zation of the membrane. The addition of 100 WM ascorbate or
42.5 mU/ml ascorbate oxidase alone to a suspension of ascor-
bate-loaded erythrocytes did not a¡ect the £uorescence. The
membrane potential was only a¡ected in presence of both
agents, irrespective of the order in which they were added
(not shown). Addition of DHA instead of ascorbate and
ascorbate oxidase did not alter the £uorescence. Also, con-
trol experiments showed that none of the additions a¡ected
DiSC3(5) £uorescence in the absence of cells. The depolariza-
tion of the erythrocytes therefore depended on the formation
of AFR in the suspension.
To further study the e¡ect of AFR on the membrane po-
tential, di¡erent amounts of AFR were generated in a suspen-
sion of ascorbate-loaded erythrocytes. This was done by vary-
ing the amount of ascorbate oxidase in a suspension
containing 100 WM ascorbate. Under similar conditions, the
corresponding AFR concentrations were measured by ESR
spectroscopy. As shown in Fig. 3, the extent of erythrocyte
depolarization, expressed as the shift in DiSC3(5) £uorescence
upon addition of AFR, depended on the concentration of
extracellular AFR in the suspension.
Depolarization of ascorbate-loaded erythrocytes in the pres-
ence of extracellular AFR shows that the reduction of AFR
must indeed be an electrogenic process. The transfer of charge
over the membrane during the reduction of AFR agrees with
the model of a transmembrane redox reaction with ascorbate
as an intracellular electron donor.
Untreated erythrocytes can also reduce extracellular AFR,
Fig. 1. Model for the ascorbate-dependent reduction of AFR. Intra-
cellular ascorbate can donate an electron to a system in the plasma
membrane, which subsequently reduces extracellular AFR. Thus, the
net oxidation of extracellular ascorbate is decreased. Intracellular
AFR is quickly regenerated to ascorbate. NADH can also serve as
an intracellular electron donor for the reduction of extracellular
AFR, but was omitted from this scheme.
Fig. 2. Depolarization of ascorbate-loaded erythrocytes in the pres-
ence of AFR. 1 WM DiSC3(5) was added to a 1% suspension of ei-
ther control or ascorbate-loaded erythrocytes at 30 s, and 100 WM
ascorbate and 42.5 mU/ml ascorbate oxidase after equilibration of
the dye at 210 s. After equilibration of the dye, an increase in £uo-
rescence indicates a depolarization of the membrane.
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albeit at a lower rate than ascorbate-loaded cells [10,12].
Nevertheless, no changes in the membrane potential were ob-
served upon exposure of control erythrocytes to AFR (Fig. 2).
We earlier showed that these cells can use NADH and endog-
enous ascorbate as electron donors for the reduction [12].
Endogenous ascorbate is typically present in the range of
20^50 WM, while ascorbate-loaded erythrocytes contained
1 mM ascorbate [27]. The most likely explanation for the
lack of change in the membrane potential of control erythro-
cytes would therefore be that the rate of charge transfer is too
low to produce a detectable e¡ect.
3.2. The e¡ect of membrane potential on AFR reduction
It is conceivable that the membrane potential of a cell af-
fects the transport of electrons over the membrane. In order
to test whether this was the case, we studied the reductase
activity by measuring the ascorbate stabilizing e¡ect of cells
[12]. In this assay, ascorbate is degraded to AFR by ascorbate
oxidase. The reduction by the cells of AFR to ascorbate de-
creases the apparent rate of this reaction. For clarity, the
di¡erence between the ascorbate oxidation rate in each sample
and the rate in bu¡er alone (3.68 WM/min) was de¢ned as the
apparent rate of AFR reduction. Several membrane potentials
were established in erythrocytes by suspending them in bu¡ers
with di¡erent concentrations of potassium and 1 WM valino-
mycin. It was found that the rate of AFR reduction was de-
pendent on the membrane potential of the erythrocytes. Hy-
perpolarization of the erythrocytes increased AFR reduction,
whereas it was decreased by a depolarization of the cells (Fig.
4). The clear correlation of the reduction rate with the mem-
brane potential con¢rms the view that electrogenic transmem-
brane electron transport is involved.
The data presented in this paper show that the reduction of
AFR by erythrocytes causes depolarization, and that depola-
rization causes decreased reduction of AFR by the ascorbate-
driven redox system. This could imply that this reduction of
AFR is auto-inhibitory. However, it must be noted that the
depolarization in our experiments required relatively high
concentrations of AFR. The levels of the radical used in
Fig. 4 were lower, and the levels in a physiological setting
will probably be even less, preventing signi¢cant changes in
the membrane potential. It is therefore unlikely that a change
in membrane potential is a limiting factor in the physiological
reduction of AFR.
3.3. Conclusion
The data in this study provide evidence for the transmem-
brane nature of the ascorbate-dependent reduction of extra-
cellular AFR by the erythrocyte. The model for the reduction
of extracellular AFR that was suggested by earlier data now
seems ¢rmly established. Intracellular ascorbate donates a sin-
gle electron to a system in the plasma membrane, which
passes it on to reduce extracellular AFR (Fig. 1). The electro-
genic nature of the electron transfer provides information on
the nature of the system in the plasma membrane. It has been
suggested that small lipid soluble molecules like K-tocopherol
and coenzyme Q can act as electron shuttles in the plasma
membrane. Thus, they could transfer electrons from e.g. intra-
cellular ascorbate to extracellular AFR. However, these elec-
tron shuttles bind a proton when accepting an electron, which
means that a proton is transported together with the electron,
and that no net charge crosses the membrane. However, our
data show that the reduction of AFR is electrogenic, which
implies that K-tocopherol or coenzyme Q do not play a major
role in this process. Instead, it is more likely that one or more
proteins in the erythrocyte membrane are involved in the elec-
tron transfer process.
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